Self-injection Devices Market to be Worth $10.8 Billion by 2030: Grand View Research, Inc.

SAN FRANCISCO, April 12, 2022 /PRNewswire/ -- The global self-injection devices market size is expected to reach USD 10.8 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 5.7% from 2022 to 2030. Increasing patient volume and rising prevalence of chronic diseases along with the high adoption of advanced drug delivery systems are factors estimated to surge the demand for self-injection devices.

Key Insights & Findings from the report:

• Needle-free injectors segment held the largest market share in 2021 owing to the rising demand for needle-free injectors and increased health consciousness among individuals.
• The disposable segment held a significant market share in 2021 due to the ease of use and the presence of a built-in glass syringe that reduces the necessity of manually loading the glass syringe, eventually making it more convenient for patients.
• The cancer segment is anticipated to gain the highest market share during the forecast period due to the increasing prevalence of cancer all across the globe.
• North America led the market in 2021 owing to the increasing demand for self-injection devices used for the treatment of several chronic diseases.
• The Asia Pacific region is expected to expand at the fastest CAGR during the forecast period due to the rising incidence of autoimmune diseases and high prevalence of cancer across several countries in the region.

Read 120-page market research report, "Self-injection Devices Market Size, Share & Trends Analysis Report By Product (Autoinjectors, Needle-free Injectors), By Usability (Disposable, Reusable), By Application (Cancer, Pain Management), By Region, And Segment Forecasts, 2022 - 2030", published by Grand View Research.

Self-injection Devices Market Growth & Trends

Prevention of needle stick injury is a primary factor for healthcare professionals and companies to introduce self-injection devices such as auto injectors. To avoid needlestick injuries to healthcare workers, the U.S., Europe, and other markets mandate the use of safety devices. Several auto-injectors provide the additional benefit of needle stick protection to healthcare professionals. It is expected that in the U.S. about 69,000 injuries can be prevented annually. Numerous auto-injectors have integral and passive safety features that eliminate or reduce the risk of injury.

Innovation in the field of New Drug Delivery Systems (NDDDS) has led to the rising demand for self-administered medications. The invention of novel injectable delivery devices such as pre-filled syringes, pen injectors, auto injectors, and needle-free injectors has made the self-administration of drugs easier and more convenient for patients. The majority of biological drugs are delivered using injections, which include the threat of needlestick injuries. To minimize this issue, pharmaceutical firms are developing self-administered needle-free injectors and patient-friendly medication-device combination products.

The COVID-19 pandemic has altered expectations and perceptions of delivery settings and contributed to a rise in preference for self-administration medication. As this becomes the norm, several manufacturers are inclined to make the patient experience the vital component of drug delivery design. Significantly, the COVID-19 vaccines will increase the demand for injectable devices and the pandemic has also shown the benefit of self-use devices as well as connected devices. Post-pandemic there may be a rise in upcoming innovation in devices and pharma manufacturers will progressively collaborate to use self-injection devices in combination with other digital assets such as apps, phones, and personal computers. Eventually, this will bring the patient into far greater control of their care.

Self-Injection Devices Market Segmentation

Grand View Research has segmented the global self-injection devices market based on product, usability, application, and region:

Self-injection Devices Product Outlook (Revenue, USD Million, 2017 - 2030)

• Auto injectors
• Pen Injectors
• Wearable Injectors
• Needle-free Injectors

Self-injection Devices Usability Outlook (Revenue, USD Million, 2017 - 2030)

• Disposable
• Reusable

Self-injection Devices Application Outlook (Revenue, USD Million, 2017 -2030)

• Cancer
• Autoimmune Disorders
• Hormonal Disorders
• Pain Management
• Others

Self-injection Devices Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• MEA
• South Africa
• Saudi Arabia
• UAE

List of Key Players in the Self-Injection Devices Market

• Amgen
• Antares Pharma
• Gerresheimer AG,
• NuGen Medical Devices,
• Pfizer, Inc.
• SHL Medical AG
• Ypsomed AG
• BD
• Haselmeier AG
• Owen Mumford Ltd

Check out more related studies published by Grand View Research:

• Injection Pen Market - The global injection pens/injectable pens/pen injectors market is expected to reach USD 67.9 billion by 2025, according to a new report by Grand View Research, Inc., registering a 9.4% CAGR during the forecast period. High demand for these devices for management of various chronic as well as acute diseases and increasing awareness in developing regions are key factors expected to drive the market.
• Disposable Syringes Market - The global disposable syringes market size is expected to reach a value of USD 9.9 billion by 2024, according to a new report by Grand View Research, Inc. The market growth can be attributed to the rising initiatives by the government and various NGOs to raise awareness about safe drug delivery to patients in order to avoid transmission of infections and avoid needle stick injuries to healthcare workers, especially in low-income countries.
• Wearable Injectors Market - The global wearable injectors market size is expected to reach USD 18.3 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 17.2% from 2021 to 2028. Wearable injectors are drug administration devices designed to deliver drugs in large volumes subcutaneously.

Browse through Grand View Research's Medical Devices Industry Research Reports.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Web: https://www.grandviewresearch.com
Grand View Compass | Grand View Pipeline
Follow Us: LinkedIn | Twitter

SOURCE Grand View Research, Inc.